Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 3Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 2Other hematologic neoplasm 1CNS 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Antibodies, Monoclonal × Gastrointestinal × Clear all
NCT06115174 2023-11-02

CRC - PTX

Tanta University

Phase 4 Unknown
44 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02254941 2022-03-16

Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer

Grupo Espanol Multidisciplinario del Cancer Digestivo

Unknown
1,104 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡